ACR适宜性标准®:肛门癌的分期与随访
本文件为ACR适宜性标准,针对肛门鳞状细胞癌初始分期、治疗后评估和监测中影像的作用给出推荐。初始局部分期时盆腔MRI和FDG-PET/CT通常适宜,补充临床和直肠指检;转移评估时CT和FDG-PET/CT通常适宜;治疗后手术指征明确时MRI和FDG-PET/CT通常适宜。
要点
- 初始局部分期:盆腔MRI和FDG-PET/CT通常适宜,可补充临床和直肠指检。
- 转移评估:CT和FDG-PET/CT通常适宜,用于检测远处淋巴结转移和其他转移灶。
- 治疗后手术指征明确时:MRI和FDG-PET/CT通常适宜,评估局部肿瘤侵犯和淋巴结转移。
核心结论
- 对于肛门鳞状细胞癌,初始局部分期通常适宜使用盆腔MRI和FDG-PET/CT;转移评估通常适宜使用CT和FDG-PET/CT;治疗后手术指征明确时通常适宜使用MRI和FDG-PET/CT。
研究设计与样本
- 美国放射学会(ACR)适宜性标准,由多学科专家小组每年审查,采用GRADE等证据分级方法,并使用RAND/UCLA适宜性方法确定影像和治療程序的适宜性。
诊断标准与关键数值
- 初始局部分期:盆腔MRI和FDG-PET/CT通常适宜,可补充临床和直肠指检,提供局部肿瘤侵犯和淋巴结转移的额外信息。
- 转移评估:CT和FDG-PET/CT通常适宜,用于检测远处淋巴结转移和其他部位转移;淋巴结、肝脏和肺部是最常见的疾病部位。
- 腹部MRI可能适宜作为问题解决工具,尤其用于评估小或不确定的肝脏病变。
- 治疗后手术指征明确时:MRI和FDG-PET/CT通常适宜,用于评估局部肿瘤侵犯和淋巴结转移。
临床应用与阅片要点
- 初始局部分期可联合盆腔MRI和FDG-PET/CT补充临床和直肠指检。
- 转移评估可使用CT和FDG-PET/CT检测远处淋巴结转移和其他转移灶。
- 评估小或不确定的肝脏病变时,腹部MRI可能适宜作为问题解决工具。
- 治疗后手术指征明确时,可使用MRI和FDG-PET/CT评估局部肿瘤侵犯和淋巴结转移。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This document aims to provide recommendations on the role of imaging in the diagnosis of squamous cell anal cancer, focusing on its use in locoregional and systemic assessment during initial staging, posttreatment evaluation, and surveillance. For initial locoregional staging, MRI of the pelvis and FDG-PET/CT are usually appropriate to complement clinical and digital rectal examinations, because they offer additional information regarding locoregional tumor invasion and nodal metastases. For metastatic disease assessment, which is rare in the initial presentation and commonly associated with recurrence-with lymph nodes, liver, and lungs being the most common sites of disease-CT and FDG-PET/CT are usually appropriate for detecting distant nodal metastases and other sites of metastatic disease. MRI of the abdomen may be appropriate as a problem-solving tool, particularly in assessing small or indeterminate liver lesions. For patients who have completed locoregional treatment, most typically achieve clinical complete response; consequently, few require surgery unless there is persistent disease or recurrence. The role of posttreatment imaging assessment is still debatable; however, in cases in which surgery is indicated, MRI and FDG-PET/CT are usually appropriate for assessing local tumor invasion and nodal metastases. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision process support the systematic analysis of the medical literature from peer reviewed journals. Established methodology principles such as Grading of Recommendations Assessment, Development, and Evaluation or GRADE are adapted to evaluate the evidence. The RAND/UCLA Appropriateness Method User Manual provides the methodology to determine the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances in which peer reviewed literature is lacking or equivocal, experts may be the primary evidentiary source available to formulate a recommendation.
引用
- Horvat N, Liu PS, Fowler KJ, et al. ACR Appropriateness Criteria® Staging and Follow-up of Anal Cancer. J Am Coll Radiol. 2025. PMID: 40409890. doi:10.1016/j.jacr.2025.02.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。